Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Umizortamig is an investigational monoclonal antibody being studied for its application in oncology. Details about its exact mechanism of action and target specificity remain limited at this stage. Generally monoclonal antibodies like Umizortamig function by binding to specific antigens on cancer cells thereby inhibiting tumor growth or marking the cells for immune-mediated destruction. Further research is required to establish its clinical utility.
仅用于科研。不用于诊断过程。未经明确授权不得转售。